Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
RenovoRx presented clinical data demonstrating that its patented Trans-Arterial Micro-Perfusion (TAMP™) therapy platform, enabled by the FDA-cleared RenovoCath® device, offers promising localized chemotherapy delivery for locally advanced pancreatic cancer. The therapy showed potential to enhance drug concentration at tumor sites, reduce systemic t…